{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Su T"],"funding":["Major Project of Natural Science Foundation of Hunan Province","Natural Science Foundation of Hunan Province","National Natural Science Foundation of China"],"pagination":["e2406500"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11558151"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(42)"],"pubmed_abstract":["The dynamic interplay between parenchymal hepatocytes and non-parenchymal cells (NPCs), such as macrophages, is an important mechanism for liver metabolic homeostasis. Although numerous endeavors have been made to identify the mediators of metabolic dysfunction associated steatohepatitis (MASH), the molecular underpinnings of MASH progression remain poorly understood, and therapies to arrest MASH progression remain elusive. Herein, it is revealed that the expression of grancalcin (GCA) is upregulated in the macrophages of patients and rodents with MASH and correlates with MASH progression. Notably, the administration of recombinant GCA aggravates the development of MASH, whereas, Gca deletion in myeloid cells blunts liver steatosis and inflammation in multiple MASH murine models. Mechanist"],"journal":["Advanced science (Weinheim, Baden-Wurttemberg, Germany)"],"pubmed_title":["Macrophage-Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis."],"pmcid":["PMC11558151"],"funding_grant_id":["2022JJ30957","92149306","82270930","2021JC0002-06"],"pubmed_authors":["Wang M","Ye M","Su T","Zhao M","He Y","Huang Y","Xiao Y","Luo X","Zhou H","Guo Q","Wang J","Cai G"],"additional_accession":[]},"is_claimable":false,"name":"Macrophage-Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis.","description":"The dynamic interplay between parenchymal hepatocytes and non-parenchymal cells (NPCs), such as macrophages, is an important mechanism for liver metabolic homeostasis. Although numerous endeavors have been made to identify the mediators of metabolic dysfunction associated steatohepatitis (MASH), the molecular underpinnings of MASH progression remain poorly understood, and therapies to arrest MASH progression remain elusive. Herein, it is revealed that the expression of grancalcin (GCA) is upregulated in the macrophages of patients and rodents with MASH and correlates with MASH progression. Notably, the administration of recombinant GCA aggravates the development of MASH, whereas, Gca deletion in myeloid cells blunts liver steatosis and inflammation in multiple MASH murine models. Mechanist","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-07-16T21:49:15.746Z","creation":"2025-04-06T22:10:13.981Z"},"accession":"S-EPMC11558151","cross_references":{"pubmed":["39279458"],"doi":["10.1002/advs.202406500"]}}